Axovant Gene Therapies
Why Robinhood?
You can watch AXGT and buy or sell other stocks, ETFs, and their options commission-free!About AXGT
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY.
AXGT Key Statistics
Stock Snapshot
The current Axovant Gene Therapies(AXGT) stock price is $0.40, with a market capitalization of 35.36M. The stock trades at a price-to-earnings (P/E) ratio of -1.22.
On 2026-04-01, Axovant Gene Therapies(AXGT) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 218.56K.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.